Business
Bath & Body Works sells body care, home fragrance, soaps and related personal-care products.
Bath & Body Works held revenue nearly flat while preserving high margins, profit and strong free cash flow, giving the fragrance brand capacity to fund its reset.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 0.2%Watch
- Profitability — Net income declined 18.7% to $649M from $798MWatch
- Cash flow — Free cash flow grew 31.1% to $865M from $660MOK
- Margins — Operating margin contracted 189 bps to 15.44%Watch
- Accounting — Strong cash generation despite flat salesNote
- Insiders — 6 purchases and 0 salesOK
Where the revenue comes from
Fiscal 2025, as Bath & Body Works, Inc. reports it. History and quarterly detail are in the app.
- Reportable$7.3B
Leadership changes
From Bath & Body Works, Inc.'s own filings, the day they're filed.
- Thomas J. Kuhn · Directors · departureeff. 2024-04-20
- Patricia S. Bellinger · Directors · departureeff. 2024-03-13
- Michael G. Morris · Directors · departureeff. 2024-03-13
Latest filings
- 8-K · Company announcement2026-08-26
- 10-Q · Quarterly report2026-08-26
- 8-K · Company announcement2026-07-20
- 8-K · Company announcement2026-06-15
- 10-Q · Quarterly report2026-05-27
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Bath & Body Works, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.